James Dahlman and Phil Santangelo are helping to
define an evolving era in medicine, one in which messenger
ribonucleic acid—mRNA—can be delivered directly to cells to fight
against disease. And their latest groundbreaking study could clear
the way to faster therapeutic discoveries.